Weisman Howard J. 4
4 · PaxMedica, Inc. · Filed Apr 14, 2023
Insider Transaction Report
Form 4
PaxMedica, Inc.PXMD
Weisman Howard J.
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2023-04-13+180,000→ 721,633 total
Footnotes (1)
- [F1]Consists of 180,000 restricted stock units ("RSUs"). The RSUs are subject to time-based vesting with one-third of the RSUs vesting on February 1, 2024, followed by 8.3325% of the remaining RSUs vesting on a quarterly basis thereafter, subject to the reporting person's continuous employment with the Company as of such vesting dates.